Edap Tms S.a. (NASDAQ: EDAP) Stock Competitors & Peer Comparison
See EDAP's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for EDAP and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EDAP | $4.76 | -0.52% | 178.2M | -5.80 | -$0.82 | N/A |
| ALC | $73.63 | +5.88% | 35B | 22.58 | $3.18 | +0.49% |
| STE | $238.91 | +0.61% | 23.3B | 22.95 | $10.42 | +1.06% |
| BRKRP | $418.44 | +4.52% | 8.4B | 228.14 | $1.84 | +0.35% |
| DRTSW | $3.46 | +1.76% | 1.4B | -5.42 | -$0.65 | N/A |
| SI | $20.75 | +0.78% | 434.7M | -10.95 | -$1.91 | N/A |
| MOBI | $12.73 | +4.00% | 423.3M | -0.68 | -$18.78 | N/A |
| MASS | $8.80 | -0.90% | 361M | -14.67 | -$0.60 | N/A |
| APYX | $3.46 | -14.57% | 145.7M | -15.73 | -$0.22 | N/A |
| NYXH | $1.58 | +7.48% | 62.6M | -0.63 | -$2.52 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
EDAP vs ALC Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, ALC has a market cap of 35B. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while ALC trades at $73.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas ALC's P/E ratio is 22.58. In terms of profitability, EDAP's ROE is -1.49%, compared to ALC's ROE of +0.04%. Regarding short-term risk, EDAP is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for EDAP.Check ALC's competition here
STERIS plc (NYSE: STE)
EDAP vs STE Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, STE has a market cap of 23.3B. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while STE trades at $238.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas STE's P/E ratio is 22.95. In terms of profitability, EDAP's ROE is -1.49%, compared to STE's ROE of +0.11%. Regarding short-term risk, EDAP is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for EDAP.Check STE's competition here
Bruker Corporation (NASDAQ: BRKRP)
EDAP vs BRKRP Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, BRKRP has a market cap of 8.4B. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while BRKRP trades at $418.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas BRKRP's P/E ratio is 228.14. In terms of profitability, EDAP's ROE is -1.49%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, EDAP is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for EDAP.Check BRKRP's competition here
Alpha Tau Medical Ltd. (NASDAQ: DRTSW)
EDAP vs DRTSW Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, DRTSW has a market cap of 1.4B. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while DRTSW trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas DRTSW's P/E ratio is -5.42. In terms of profitability, EDAP's ROE is -1.49%, compared to DRTSW's ROE of -0.73%. Regarding short-term risk, EDAP is less volatile compared to DRTSW. This indicates lower risk in terms of short-term price fluctuations for EDAP.Check DRTSW's competition here
Shoulder Innovations, Inc. (NYSE: SI)
EDAP vs SI Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, SI has a market cap of 434.7M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while SI trades at $20.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas SI's P/E ratio is -10.95. In terms of profitability, EDAP's ROE is -1.49%, compared to SI's ROE of -0.24%. Regarding short-term risk, EDAP is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for EDAP.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
EDAP vs MOBI Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, MOBI has a market cap of 423.3M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while MOBI trades at $12.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas MOBI's P/E ratio is -0.68. In terms of profitability, EDAP's ROE is -1.49%, compared to MOBI's ROE of +0.31%. Regarding short-term risk, EDAP is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for EDAP.Check MOBI's competition here
908 Devices Inc. (NASDAQ: MASS)
EDAP vs MASS Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, MASS has a market cap of 361M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while MASS trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas MASS's P/E ratio is -14.67. In terms of profitability, EDAP's ROE is -1.49%, compared to MASS's ROE of -0.26%. Regarding short-term risk, EDAP is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for EDAP.Check MASS's competition here
Apyx Medical Corporation (NASDAQ: APYX)
EDAP vs APYX Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, APYX has a market cap of 145.7M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while APYX trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas APYX's P/E ratio is -15.73. In terms of profitability, EDAP's ROE is -1.49%, compared to APYX's ROE of -0.79%. Regarding short-term risk, EDAP is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for EDAP.Check APYX's competition here
Nyxoah S.A. (NASDAQ: NYXH)
EDAP vs NYXH Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, NYXH has a market cap of 62.6M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while NYXH trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas NYXH's P/E ratio is -0.63. In terms of profitability, EDAP's ROE is -1.49%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, EDAP is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for EDAP.Check NYXH's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
EDAP vs MDAI Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, MDAI has a market cap of 54.4M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while MDAI trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas MDAI's P/E ratio is -3.80. In terms of profitability, EDAP's ROE is -1.49%, compared to MDAI's ROE of +1.79%. Regarding short-term risk, EDAP is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for EDAP.Check MDAI's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
EDAP vs WOK Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while WOK trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas WOK's P/E ratio is N/A. In terms of profitability, EDAP's ROE is -1.49%, compared to WOK's ROE of -0.07%. Regarding short-term risk, EDAP is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for EDAP.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
EDAP vs QTEXW Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, EDAP's ROE is -1.49%, compared to QTEXW's ROE of N/A. Regarding short-term risk, EDAP is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for EDAP.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
EDAP vs ITOC Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, ITOC has a market cap of 2.7M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while ITOC trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas ITOC's P/E ratio is -0.93. In terms of profitability, EDAP's ROE is -1.49%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, EDAP is more volatile compared to ITOC. This indicates higher risk in terms of short-term price fluctuations for EDAP.Check ITOC's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
EDAP vs BIAFW Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, BIAFW has a market cap of 2.1M. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while BIAFW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas BIAFW's P/E ratio is 0.23. In terms of profitability, EDAP's ROE is -1.49%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, EDAP is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for EDAP.Check BIAFW's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
EDAP vs FEED Comparison August 2026
Edap Tms S.a. (NASDAQ: EDAP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDAP stands at 178.2M. In comparison, FEED has a market cap of 455.5K. Regarding current trading prices, EDAP is priced at $4.76 on the NASDAQ, while FEED trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDAP currently has a P/E ratio of -5.80, whereas FEED's P/E ratio is -0.01. In terms of profitability, EDAP's ROE is -1.49%, compared to FEED's ROE of -0.44%. Regarding short-term risk, EDAP is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for EDAP.Check FEED's competition here